Twenty-four human rhinovirus serotypes were grown and purified by centrifugation in metrizamide density gradients. These preparations had a lower buoyant density (1.24 gecm3) and higher specific infectivities (1:24 to 1:240) than did rhinoviruses described previously (E. J. Stott and R. J. Killington, Annu. Rev. Microbiol. 26:503-524, 1972). Binding conditions in which the unique cellular receptors for virus attachment were saturated were determined for each serotype. Competition binding assays between pairs of serotypes allowed 20 of the 24 serotypes to be assigned to the same cellular receptor. The remaining four serotypes appeared to attach to a different cellular receptor. Since most serotypes were chosen for study at random, it seems likely that many of the yet unstudied rhinoviruses will share this common cellular receptor.
Picornaviruses attach to animal cells by specific receptors on the cell surface (2) . Frequently, the possession of appropriate cellular receptors is sufficient to determine the host range for a particular virus. This can be illustrated by poliovirus, which replicates naturally only in cells of primate origin. Other genera of the Picornaviridae family, including the rhinoviruses, appear to bind to different cellular receptors (10, 11, 14, 20) . The attachment of human rhinoviruses to cells is generally species specific (7), although some serotypes will replicate in cells of either monkeys (15) or chimpanzees (3) . The rates at which human rhinoviruses attach to cells is temperature dependent and may vary by a factor of up to 20 (11) . The number of rhinovirus receptor sites per cell of human origin has been estimated to be from 104 for serotypes 2 and 14 (11) to greater than 106 for serotype 18 (12) . Such cellular receptors are sensitive to the action of proteolytic enzymes (18) . Since the number of cellular receptors on the cell surface is limited, it is possible to saturate them with virus particles of one serotype and examine the binding of another serotype in competition binding assays. Previous analyses have shown that rhinovirus serotypes 1A and 2 share a common cellular receptor which is different from the cellular receptor utilized by serotypes 3, 14, and 51 (10, 11) .
As many as 115 serotypes of human rhinoviruses have been identified (13) on the basis of serological reactions, with very little antigenic cross-reactivity among them (1) . This investigation was initiated to establish if this large group of related viruses attaches to susceptible cells by a similarly large variety of cellular receptors.
MATERIALS AND METHODS
Cell and virus growth. HeLa cells were cloned, and a clone (designated HeLa R-19) was selected on the basis of its ability to support the rapid growth of rhinovirus. HeLa R-19 cells were propagated in monolayers in McCoy 5A medium containing 5% fetal calf serum. Mouse L cells were grown similarly.
Rhinovirus serotypes were obtained from the American Type Culture Collection and were grown in HeLa R-19 cell monolayers. As soon as working stock cultures were obtained, the authenticity of each serotype was verified by neutralization with the specific antiserum obtained from the * Corresponding author. Purification of viruses. Infected cell cultures were harvested when cells detached freely from the flask surface (usually after 16 to 24 h). The supernatant fluid was frozen and quickly thawed to release virus particles from the cells. After clarification by centrifugation at slow speed (4,000 x g for 5 min), polyethylene glycol 6000 and NaCl were added to 7 and 2.2%, respectively, and the mixture was stirred at 4°C for 4 to 16 h. The precipitated virus was recovered by centrifugation (10,500 x g for 15 min) and suspended in R buffer (10 mM Tris-hydrochloride [pH 7.5], 0.2 M NaCl, 50 mM MgCl2, 10% [wt/vol] glycerol). Sodium deoxycholate and Nonidet P-40 were added to 0.3 and 0.6%, respectively, for 30 min at 4°C, and the suspension was clarified by centrifugation (4,000 x g for 5 min). The supernatant (7.5 ml) was layered over a 5-ml linear density gradient of 40 to 60% (wt/vol) metrizamide in R buffer lacking glycerol. Isopycnic banding of the virus sample was achieved by centrifugation for 24 h at 150,000 x g in a Beckman ,SW40 rotor. Virus bands were generally the densest of the visible bands in the gradient and were harvested visually. After dilution in 10 volumes of R buffer, the virus was repelleted by centrifugation at 200,000 x g for 2 h. Virus pellets were suspended in a small volume of phosphate-buffered saline and stored frozen at -70°C. Infectivity titrations were done by plaque assay in HeLa R-19 cells by standard procedures.
Radioactively labeled virus was concentrated by polyethylene glycol precipitation as described above but was generally layered over an 11-ml linear density gradient of 5 to 20% (wt/vol) sucrose in R buffer. After centrifugation for 2 h at 150,000 x g in a Beckman SW40 rotor, the gradients were fractionated (0.4 ml) into tubes containing 0. Blocking caused by the prior binding of heterologous viruses was assayed similarly. Concentrations of each virus that caused (in most cases) a greater than 80% blocking of binding of the homologous virus were established from the assays described above. The appropriate concentrations of viruses were then used to saturate the receptor sites before challenge bindings with 35S-labeled heterologous viruses as described above. In such assays, the binding of the labeled virus to control cells was used for calculating the percentages of binding.
Materials. Metrizamide was manufactured by Nyegaard and Co., Oslo, Norway, and L-[35S]methionine (1, 200 Ci/ mmol) was purchased from Amersham International. RESULTS Purification of rhinoviruses. Virus preparations used in studying the interactions of rhinoviruses with HeLa cells were recovered from infected cell lysates by concentration with polyethylene glycol. Virus particles were resolved from contaminating debris by centrifugation overnight in preformed metrizamide density gradients. Rhinoviruses invariably formed visible bands at a higher density than did contaminating particles. Rhinoviruses prepared by centrifugation in metrizamide solutions consisted of uniform, characteristic particles when examined by electron microscopy. Very few empty capsids were present (data not shown). As an additional check on the purity of viruses prepared in this way, samples were radioiodinated by standard procedures, and the labeled proteins were analyzed by sodium dodecyl sulfate-acrylamide gel electrophoresis. The only labeled (A) [35] methionine-labeled rhinovirus type 89 was prepared as described in the text and analyzed by centrifugation for 2 h at 150,000 x g through a 5 to 20% (wt/vol) sucrose density gradient. The gradient was fractionated from the top into 0.4-ml fractions, and a portion of each was used for the determination of35S radioactivity (0) or infectivity (0). (B) Samples from the two peak fractions representing intact virions (0) and empty capsids (0) in (A) were diluted with 7.5 ml of R buffer and layered separately over two 5-mi linear gradients of 40 to 60%o (wt/vol) metrizamide. After centrifugation for 48 h at 150,000x g in a BeckmanSW40 rotor, the gradients were fractionated into 60 0.2-ml fractions. Total radioactivity was determined, and the central part of each profile was depicted. Density determinations on the gradient fractions containing the virus particles were done as described in the text. Sedimentation in each case was from left to right. products detected by autoradiography were the viral structure proteins for the particular serotype (data not shown). Rhinovirus preparations for serotypes IA, 11, and 14 were examined by electron microscopy in the presence of a known concentration of standard latex particles. The concentrations of viral particles were determined, and these concentrations, when coupled with the infectivity titers of the preparations, allowed estimates to be made of the infectivity/particle ratios for the three viruses tested. These values of 1:24, 1:65, and 1:240 for serotypes 1A, 11, and 14, respectively, were more than 20 times the previous estimates (12) made with viruses purified by centrifugation in cesium chloride density gradients.
Rhinoviruses grown in the presence of [35S]methionine were usually resolved from empty capsids and other labeled components by rate zonal centrifugation in sucrose density gradients (Fig. 1A) . Fractions containing the virus were either frozen directly or diluted with buffer and analyzed further by centrifugation in metrizamide density gradients (Fig. 1B) . In Fig. 1 The radiochemical purity of the rhinoviruses purified by sucrose gradients alone was checked by analysis of the labeled proteins after sodium dodecyl sulfate-gel electrophoresis. Profiles for both the empty capsids and the viral particles of serotypes 17, 5, and 15 are shown in Fig. 2 . The VPO protein present in the empty capsids can be readily identified, as it is cleaved to give VP2 and VP4 upon maturation of the virus particle. In the case of serotype 15, the VPO protein migrated faster than did VP1, and the VP4 protein apparently lacked a methionine residue.
The proteins of all rhinovirus serotypes used in this study were analyzed similarly, and in all cases, negligible radioactivity was found in protein bands other than those of the viral structural proteins. Analysis of the proteins of viruses purified by metrizamide gradient banding revealed profiles indistinguishable from those shown in Fig. 2 In all assays described, the amount of radioactivity virus added was such that the multiplicity of infectious particles added per cell never exceeded one. Our estimates of the infectivity of our preparations and the published values for the number of receptor sites for rhinoviruses on human cells (11, 12) indicate that the conditions for the binding of radioactive viruses in these assays were well below saturation. Nevertheless, the proportion of any preparation of 35S-labeled virus that bound to HeLa R-19 monolayers within a 1-h period was rarely above 50%.
Blocking of binding by homologous virus. Previous studies by Lonberg-Holm and Korant (11) have shown that saturation of the cell surface receptors can be achieved if the multiplicity of the adsorbed virus is high enough. Such conditions were determined for each of the purified rhinovirus serotypes used in this work. Figure 4 shows the homologous interference provided by the binding of serotypes 
DISCUSSION
Purification of rhinoviruses by banding in metrizamide gradients resulted in virus preparations with specific infectivities at least 20 times higher than those reported for viruses purified similarly in cesium chloride gradients (8) . This observation is consistent with various reports (5, 16, 17) that high concentrations of cesium salts alter the structural integrity of rhinovirus particles. Such changes alter the sedimentation characteristics (8), the antigenic neutralization by specific antisera (5), the stability of the viral RNA (4) , and the buoyant density of the virus particles (8, 17) . When the buoyant densities of rhinoviruses were measured by equilibrium sedimentation in metrizamide solutions, a value of 1.24 g/cm3 was obtained for serotype 89 (Fig. 1B) found to be specific and similar to those described previously ( [10] [11] [12] . The relatively high specific activity of the radiolabeled virus particles allowed a low multiplicity of infectious particles to be used in the binding assays. Thus, the saturation level of the cell receptors was never approached during the binding of 35S-labeled virus. The fact that less than 50% of [35S]methionine-labeled virus would bind to an excess of cell receptors during a 40-to 60-min period may be explained in terms of the infectivity/particle ratio of virus preparations, where much of the radioactivity was present in noninfectious, nonbinding particles. The lowest level of binding was shown by serotype 14, for which binding values of only 10% were reproducibly obtained. This observation is consistent with a previous report that serotype 14 binds relatively poorly to host cells (10) .
Saturating levels of virus particles could be added to cells such that further addition of virus resulted in negligible further binding (Fig. 4) . This principle could be extended to examine the interaction of heterologous viruses with cell receptors. Such experiments have been reported in a limited way in previous reports (10, 11) . The conclusions of those researchers were that at least two families of cellular receptors were present on human cells; serotypes 1A and 2 shared the same receptor site, whereas serotypes 3, 14, and 51 shared another site (10, 11) . Further unpublished observations of these researchers (10) have indicated that serotypes 5, 15, 39, and 41 are also related to serotype 14.
Our work considerably extends these observations and examines the interrelationships among 24 serotypes in an almost reciprocal fashion. Serotypes 1A, 2, 44, and 49 showed virtually no cross-reactivity with any of the other 20 serotypes examined (Table 1, 2, and 3 ). This result confirmed previous observations that serotypes 1A and 2 were 
